VIRGINIA BEACH, Va., June 16 /PRNewswire/ — LifeNet Health, a
leading allograft bio-implant and regenerative material company, is
pleased to announce two key publications regarding its innovative
OsteoCleanse™ autograft cleaning service for the treatment of
infected or contaminated cranial bone flaps.
OsteoCleanse™ is one of several advanced technology
platforms that LifeNet Health utilizes to help restore health.
Thousands of decompressive craniectomies are performed each
year, often as the result of traumatic brain injuries (TBIs).
Using OsteoCleanse™, the resultant autografts are
placed in a custom container, shipped to LifeNet Health,
disinfected, labeled, and stored until re-implantation.
OsteoCleanse™ is the first process of its kind
specifically designed for autologous tissue and is based on LifeNet
Health’s patented allograft treatment technologies which have been
used since 1995 to clean, disinfect, and sterilize allograft tissue
to remove risk of disease transmission.
“We are excited that OsteoCleanse™ is receiving national
attention in these publications. Through the OsteoCleanse™
autograft cleaning service, LifeNet Health is continuing to advance
technology and offer solutions to help restore health and save
lives,” said Rony Thomas, LifeNet
Health CEO and President.
Dr. Scott Graham from the
Department of Neurosurgery at the Virginia
Commonwealth University pioneered the use of
OsteoCleanse™. His first case series is described in
“Salvage of contaminated cranial bone flap autografts using
OsteoCleanseTM: pilot study case reports” (J. Cell
Tissue Bank (2010) 11:155–172). Dr. Gra
‘/>”/>
